Role of Cardiac Magnetic Resonance Imaging-Derived Tissue Characterization in Cardiac Sarcoidosis: Experience from a Tertiary Referral Center of India
Open Access
- 15 July 2026
- journal article
- Published by Georg Thieme Verlag KG in Indian Journal of Radiology and Imaging
Abstract
Cardiac magnetic resonance imaging (MRI) using T1 mapping, T2 mapping, and late gadolinium enhancement (LGE) may help in the comprehensive assessment of cardiac sarcoidosis. This prospective study included patients with proven extracardiac sarcoidosis and with suspected cardiac involvement based on clinical features. A total of 25 patients were screened, and 19 patients with confirmed pulmonary sarcoidosis were finally included for analysis. Six normal controls were included. The average age (n = 19) was 38 years. The most common presentation was palpitations (68.4%) and dyspnea (52.63%). Erythrocyte sedimentation rate, C-reactive protein, and angiotensin-converting enzyme were elevated in 11 (57.89%), 8 (42.11%), and 9 patients, respectively. A total of 12 (63.15%) patients had LGE on MRI. LGE pattern was predominantly patchy and multisegmental, with mid-myocardial involvement present in 11 (91.6%) and subepicardial extension in 8 (66.67%) of the 12 LGE-positive patients, often in combination. At a cutoff value of 1,029 ms, T1 mapping had a sensitivity of 87.5% and a specificity of 96.9% in detecting an involved segment (with LGE). Using this cutoff in seven patients with suspected cardiac sarcoidosis who were LGE-negative, we observed elevated T1 mapping values in 38 out of 112 segments, with all patients showing abnormalities in at least one segment; both the patients who underwent positron emission tomography (PET) imaging in this subgroup showed active myocardial inflammation. Among patients with both MRI and PET-CT (n = 10), MRI and PET were able to detect active disease in five and eight patients, respectively; however, this difference was not statistically significant (p = 0.44). T2 mapping values were significantly increased in basal anterior, basal inferior, and apical lateral segments in sarcoidosis patients compared with controls. Cardiac MRI with T1, T2 mapping and LGE have excellent performance in assessing myocardial involvement in patients suspected of having cardiac sarcoidosis. Cardiac MRI with T1 mapping, T2 mapping and late gadolinium enhancement have excellent performance in detecting myocardial involvement in patients with suspected cardiac sarcoidosis.Keywords
This publication has 15 references indexed in Scilit:
- Morphologic Features of Cardiac Sarcoidosis in Native Hearts of Patients Having Cardiac TransplantationThe American Journal of Cardiology, 2014
- Delayed Contrast Enhancement on MR Images of Myocardium: Past, Present, FutureRadiology, 2011
- Pulmonary Sarcoidosis: Typical and Atypical Manifestations at High-Resolution CT with Pathologic CorrelationRadioGraphics, 2010
- Cardiac sarcoidosisAmerican Heart Journal, 2009
- The Role of Endomyocardial Biopsy in the Management of Cardiovascular DiseaseCirculation, 2007
- A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathyAmerican Heart Journal, 2005
- The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial DysfunctionNew England Journal of Medicine, 2000
- Pulmonary sarcoidosis: correlation of CT and histopathologic findings.Radiology, 1993
- Pulmonary sarcoidosis: evaluation with high-resolution CT.Radiology, 1989
- Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.Circulation, 1978